↓ Skip to main content

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

Overview of attention for article published in Lancet Neurology, December 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
6 X users
patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
78 Dimensions

Readers on

mendeley
205 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
Published in
Lancet Neurology, December 2018
DOI 10.1016/s1474-4422(18)30391-0
Pubmed ID
Authors

Ralf Reilmann, Andrew McGarry, Igor D Grachev, Juha-Matti Savola, Beth Borowsky, Eli Eyal, Nicholas Gross, Douglas Langbehn, Robin Schubert, Anna Teige Wickenberg, Spyros Papapetropoulos, Michael Hayden, Ferdinando Squitieri, Karl Kieburtz, G Bernhard Landwehrmeyer, European Huntington's Disease Network, Huntington Study Group investigators, Pinky Agarwal, Karen E Anderson, Nasir A Aziz, Jean-Phillippe Azulay, Anne C Bachoud-Levi, Roger Barker, Agnieszka Bebak, Markus Beuth, Kevin Biglan, Stephanie Blin, Stefan Bohlen, Raphael Bonelli, Sue Caldwell, Fabienne Calvas, Jonielyn Carlos, Simona Castagliuolo, Terrence Chong, Phyllis Chua, Allison Coleman, Jody Corey-Bloom, Rebecca Cousins, David Craufurd, Jill Davison, Eric Decorte, Giuseppe De Michele, Laura Dornhege, Andrew Feigin, Stephanie Gallehawk, Pascale Gauteul, Carey Gonzales, Jane Griffith, Alexander Gustov, Mark Guttman, Beatrix Heim, Hope Heller, Lena Hjermind, Sergey Illarioshkin, Larry Ivanko, Jessica Jaynes, Mollie Jenckes, Barbara Kaminski, Anne Kampstra, Agnieszka Konkel, Svetlana Kopishinskaya, Pierre Krystkowiak, Suresh K Komati, Alexander Kwako, Stefan Lakoning, Guzal Latipova, Blair Leavitt, Clement Loy, Cheryl MacFarlane, Louise Madsen, Karen Marder, Sarah Mason, Neila Mendis, Tilak Mendis, Andrea Nemeth, Louise Nevitt, Virginia Norris, Christine O'Neill, Audrey Olivier, Michael Orth, Ashley Owens, Peter Panegyres, Susan Perlman, Joy Preston, Josef Priller, Alicja Puch, Oliver Quarrell, Domenica Ragosta, Amandine Rialland, Hugh Rickards, Anna M Romoli, Christopher Ross, Anne Rosser, Monika Rudzinska, Cinzina V Russo, Carsten Saft, Victoria Segro, Klaus Seppi, Barbara Shannon, David Shprecher, Clemence Simonin, Zara Skitt, Jaroslaw Slawek, Paola Soliveri, Sandro Sorbi, Ferdinando Squitieri, Valarie Suski, Iwona Stepniak, Park Sungmee, Sofia Temirbaeva, Claudia Testa, Anette Torvin-Moller, Stefanie Uhl, Christina Vangsted-Hansen, Christophe Verny, Paola Wall, Francis Walker, Paula Wasserman, Grzegorz Witkowski, Jan Wright, Zuleykha Zalyalova, Daniel Zielonka

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 205 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 205 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 11%
Student > Master 22 11%
Student > Ph. D. Student 20 10%
Other 17 8%
Student > Bachelor 17 8%
Other 26 13%
Unknown 81 40%
Readers by discipline Count As %
Medicine and Dentistry 35 17%
Neuroscience 25 12%
Nursing and Health Professions 12 6%
Psychology 10 5%
Pharmacology, Toxicology and Pharmaceutical Science 9 4%
Other 25 12%
Unknown 89 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 June 2023.
All research outputs
#1,732,367
of 25,411,814 outputs
Outputs from Lancet Neurology
#1,097
of 4,012 outputs
Outputs of similar age
#38,939
of 444,386 outputs
Outputs of similar age from Lancet Neurology
#22
of 60 outputs
Altmetric has tracked 25,411,814 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,012 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.7. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,386 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.